Lamdong Pharmaceutical Joint Stock Company reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported revenue was VND 42,846.98 million compared to VND 49,612.48 million a year ago. Net loss was VND 6,373.69 million compared to net income of VND 1,620.92 million a year ago.

Basic loss per share from continuing operations was VND 502 compared to basic earnings per share from continuing operations of VND 128 a year ago. Diluted loss per share from continuing operations was VND 502 compared to diluted earnings per share from continuing operations of VND 128 a year ago.